FDA says Mylan’s EpiPen is in shortage
(Reuters) – U.S. regulators said on Wednesday that Mylan NV’s (MYL.O) EpiPen products are in shortage, due to manufacturing delays that are creating intermittent supply constraints of the emergency allergy…
Nestle to pay Starbucks $7.15 billion in global coffee alliance
LONDON/ZURICH (Reuters) – Swiss-based food giant Nestle will pay Starbucks $7.15 billion in cash for the rights to sell the U.S. coffee chain’s products around the world, tying a premium…
Talks between Swiss Re and SoftBank close to collapsing: FT
ZURICH (Reuters) – Discussions between Swiss Re (SRENH.S) and SoftBank (9984.T) about the Japanese group potentially taking a stake in the reinsurer are faltering, the Financial Times reported on Sunday,…
Tesla’s Musk calls Wall Street snub ‘foolish’ but defends his behavior
(Reuters) – Tesla Inc (TSLA.O) Chief Executive Officer Elon Musk acknowledged on Friday that it was “foolish” of him to snub analysts on a conference call earlier in the week,…
Buffett’s Berkshire swings to rare loss but performs better
OMAHA, Neb. (Reuters) – Warren Buffett lost money but had a pretty good quarter. A shareholder takes a picture of a drawing of Warren Buffett at the Berkshire Hathaway Inc…
Regeneron/Sanofi cut heart drug price to $4,500-$6,600 for Express Scripts
(Reuters) – Regeneron Pharmaceuticals Inc and Sanofi SA will slash the price of their expensive cholesterol drug for Express Scripts Holdings Co customers in exchange for greater patient access, with…
Jilted Akorn sues Fresenius over deal termination
FRANKFURT (Reuters) – U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled their $4.75 billion takeover agreement. FILE PHOTO: Fresenius headquarters in…
Musk insists Tesla does not need more capital, predicts profit soon
(Reuters) – Tesla Inc (TSLA.O) will be profitable in the third and fourth quarters of this year and will not have to raise any money from investors, billionaire Chief Executive…
Biotech M&A rolls on as Alex ion snaps up Wilson for $855 mln
(Reuters) – Alex ion Pharmaceuticals has agreed to buy Sweden’s Wilson Therapeutics for 7.1 billion Swedish crowns ($855 million), boosting its line-up of rare disease drugs as a wave of…
Trump taking ‘serious look’ at policy options on Amazon
Aboard Air Force One (Reuters) – U.S. President Donald Trump said on Thursday he would take a serious look at policies to address what he says are the unfair business…